Content area

|
|

Gastrisk aspirationsbehandling er et muligt alternativ til behandling af fedme

Forfatter(e)
Marie Møller Christensen1, Tina Jorsal1, Lars Peter Skat Naver2, Tina Vilsbøll1 & Filip Krag Knop1 1) Center for Diabetesforskning, Gentofte Hospital 2) Privathospitalet Møn Ugeskr Læger 2017;179:V03170198
Reference: 
Ugeskr Læger 2017;179:V03170198
Blad nummer: 
Sidetal: 
2-5
Gastric aspiration therapy is a possible alternative to treatment of obesity
Aspiration therapy with AspireAssist is a novel endoscopic obesity treatment. Patients aspirate about 30% of an ingested meal through a draining system via a percutanous endoscopic gastrostomy tube. AspireAssist was recently approved by the FDA, and it induces weight loss comparable to bariatric surgery but with a lower risk. Few clinical studies about the efficacy/safety of AspireAssist have been carried out, so further intervention studies evaluating acute and long-term effects are warranted.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Hans Erik Brygger | 24/06
3 kommentarer
af Jennifer Vikre-Jørgensen | 22/06
2 kommentarer
af Susanne L. M. Bülow | 19/06
2 kommentarer
af Niels Ejnar Bie | 18/06
2 kommentarer
af Hanne Hermann | 17/06
1 Kommentar
af Julius Vindbjerg Nissen | 17/06
1 Kommentar
af Peter Tagmose Thomsen | 15/06
1 Kommentar